{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T17:40:01Z","timestamp":1789494001164,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T00:00:00Z","timestamp":1665705600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T00:00:00Z","timestamp":1665705600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s10549-022-06758-2","type":"journal-article","created":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T04:02:49Z","timestamp":1665720169000},"page":"657-664","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Oncologic safety of axillary lymph node dissection with immediate lymphatic reconstruction"],"prefix":"10.1007","volume":"196","author":[{"given":"Hope M.","family":"Guzzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie A.","family":"Valente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham S.","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayat","family":"ElSherif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen R.","family":"Grobmyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cagri","family":"Cakmakoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risal","family":"Djohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie E.","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra","family":"Pratt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2383-0499","authenticated-orcid":false,"given":"Zahraa","family":"Al-Hilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,14]]},"reference":[{"issue":"6","key":"6758_CR1","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/S1470-2045(13)70076-7","volume":"14","author":"T DiSipio","year":"2013","unstructured":"DiSipio T, Rye S, Newman B, Hayes S (2013) Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol 14(6):500\u2013515","journal-title":"Lancet Oncol"},{"issue":"4","key":"6758_CR2","doi-asserted-by":"publisher","first-page":"379","DOI":"10.21037\/gs.2017.11.04","volume":"7","author":"TC Gillespie","year":"2018","unstructured":"Gillespie TC, Sayegh HE, Brunelle CL, Daniell KM, Taghian AG (2018) Breast cancer-related lymphedema: risk factors, precautionary measures, and treatments. Gland Surg 7(4):379\u2013403","journal-title":"Gland Surg"},{"issue":"32","key":"6758_CR3","doi-asserted-by":"publisher","first-page":"5213","DOI":"10.1200\/JCO.2008.16.3725","volume":"26","author":"SA McLaughlin","year":"2008","unstructured":"McLaughlin SA, Wright MJ, Morris KT, Giron GL, Sampson MR, Brockway JP et al (2008) Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements. J Clin Oncol 26(32):5213\u20135219","journal-title":"J Clin Oncol"},{"issue":"3","key":"6758_CR4","doi-asserted-by":"publisher","first-page":"373e","DOI":"10.1097\/PRS.0000000000007636","volume":"147","author":"AR Johnson","year":"2021","unstructured":"Johnson AR, Fleishman A, Granoff MD, Shillue K, Houlihan MJ, Sharma R et al (2021) Evaluating the impact of immediate lymphatic reconstruction for the surgical prevention of lymphedema. Plast Reconstr Surg 147(3):373e-e381","journal-title":"Plast Reconstr Surg"},{"issue":"2","key":"6758_CR5","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/SAP.0000000000002862","volume":"88","author":"F Fallahian","year":"2022","unstructured":"Fallahian F, Tadisina KK, Xu KY (2022) Efficacy of microsurgical treatment of primary lymphedema. Ann Plast Surg 88(2):195\u2013199","journal-title":"Ann Plast Surg"},{"issue":"5","key":"6758_CR6","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1097\/PRS.0b013e3182a4d626","volume":"132","author":"DW Chang","year":"2013","unstructured":"Chang DW, Suami H, Skoracki R (2013) A prospective analysis of 100 consecutive lymphovenous bypass cases for treatment of extremity lymphedema. Plast Reconstr Surg 132(5):1305\u20131314","journal-title":"Plast Reconstr Surg"},{"issue":"3","key":"6758_CR7","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1245\/s10434-008-0270-y","volume":"16","author":"F Boccardo","year":"2009","unstructured":"Boccardo F, Casabona F, de Cian F, Friedman D, Villa G, Bogliolo S et al (2009) Lymphedema microsurgical preventive healing approach: a new technique for primary prevention of arm lymphedema after mastectomy. Ann Surg Oncol 16(3):703\u2013708","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"6758_CR8","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1002\/micr.22254","volume":"34","author":"F Boccardo","year":"2014","unstructured":"Boccardo F, Casabona F, DeCian F, Friedman D, Murelli F, Puglisi M et al (2014) Lymphatic microsurgical preventing healing approach (LYMPHA) for primary surgical prevention of breast cancer-related lymphedema: over 4 years follow-up. Microsurgery 34(6):421\u2013424","journal-title":"Microsurgery"},{"issue":"2","key":"6758_CR9","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/jso.25513","volume":"120","author":"GS Schwarz","year":"2019","unstructured":"Schwarz GS, Grobmyer SR, Djohan RS, Cakmakoglu C, Bernard SL, Radford D et al (2019) Axillary reverse mapping and lymphaticovenous bypass: lymphedema prevention through enhanced lymphatic visualization and restoration of flow. J Surg Oncol 120(2):160\u20137","journal-title":"J Surg Oncol"},{"key":"6758_CR10","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.jss.2017.10.008","volume":"244","author":"M Hahamoff","year":"2019","unstructured":"Hahamoff M, Gupta N, Munoz D, Lee BT, Clevenger P, Shaw C et al (2019) A lymphedema surveillance program for breast cancer patients reveals the promise of surgical prevention. J Surg Res 244:604\u2013611","journal-title":"J Surg Res"},{"issue":"10","key":"6758_CR11","doi-asserted-by":"publisher","first-page":"3296","DOI":"10.1245\/s10434-015-4721-y","volume":"22","author":"S Feldman","year":"2015","unstructured":"Feldman S, Bansil H, Ascherman J, Grant R, Borden B, Henderson P et al (2015) Single institution experience with lymphatic microsurgical preventive healing approach (LYMPHA) for the primary prevention of lymphedema. Ann Surg Oncol 22(10):3296\u20133301","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"6758_CR12","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1097\/SLA.0000000000002827","volume":"270","author":"T Ozmen","year":"2019","unstructured":"Ozmen T, Lazaro M, Zhou Y, Vinyard A, Avisar E (2019) Evaluation of simplified lymphatic microsurgical preventing healing approach (S-LYMPHA) for the prevention of breast cancer-related clinical lymphedema after axillary lymph node dissection. Ann Surg 270(6):1156\u20131160","journal-title":"Ann Surg"},{"issue":"3","key":"6758_CR13","doi-asserted-by":"publisher","first-page":"385e","DOI":"10.1097\/PRS.0000000000007098","volume":"146","author":"M Coriddi","year":"2020","unstructured":"Coriddi M, Dayan J, Mehrara B (2020) Nomenclature in lymphedema surgery. Plast Reconstr Surg 146(3):385e-e386","journal-title":"Plast Reconstr Surg"},{"issue":"11","key":"6758_CR14","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1002\/cncr.25096","volume":"116","author":"I Bedrosian","year":"2010","unstructured":"Bedrosian I, Babiera GV, Mittendorf EA, Kuerer HM, Pantoja L, Hunt KK et al (2010) A phase I study to assess the feasibility and oncologic safety of axillary reverse mapping in breast cancer patients. Cancer 116(11):2543\u20138","journal-title":"Cancer"},{"issue":"1","key":"6758_CR15","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12957-020-01886-9","volume":"18","author":"S Liu","year":"2020","unstructured":"Liu S, Wang N, Gao P, Liu P, Yang H, Xie F et al (2020) Using the axillary reverse mapping technique to screen breast cancer patients with a high risk of lymphedema. World J Surg Oncol 18(1):118","journal-title":"World J Surg Oncol"},{"issue":"7","key":"6758_CR16","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1245\/s10434-014-3626-5","volume":"21","author":"E Schunemann","year":"2014","unstructured":"Schunemann E, D\u00f3ria MT, Silvestre JBCH, Gasperin P, Cavalcanti TCS, Budel VM (2014) Prospective study evaluating oncological safety of axillary reverse mapping. Ann Surg Oncol 21(7):2197\u20132202","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"6758_CR17","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1016\/j.ejso.2020.10.031","volume":"47","author":"M Gennaro","year":"2021","unstructured":"Gennaro M, Listorti C, Mariani L, Maccauro M, Bianchi G, Capri G et al (2021) Oncological safety of selective axillary dissection after axillary reverse mapping in node-positive breast cancer. Eur J Surg Oncol 47(7):1606\u20131610","journal-title":"Eur J Surg Oncol"},{"issue":"5","key":"6758_CR18","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/j.surg.2014.05.011","volume":"156","author":"D Ochoa","year":"2014","unstructured":"Ochoa D, Korourian S, Boneti C, Adkins L, Badgwell B, Klimberg VS (2014) Axillary reverse mapping: five-year experience. Surgery 156(5):1261\u20131268","journal-title":"Surgery"},{"key":"6758_CR19","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.ijsu.2020.01.152","volume":"75","author":"MI Abdelhamid","year":"2020","unstructured":"Abdelhamid MI, Bari AA, Farid MI, Nour H (2020) Evaluation of axillary reverse mapping (ARM) in clinically axillary node negative breast cancer patients - randomised controlled trial. Int J Surg 75:174\u2013178","journal-title":"Int J Surg"},{"issue":"12","key":"6758_CR20","doi-asserted-by":"publisher","first-page":"4695","DOI":"10.1245\/s10434-020-08890-z","volume":"27","author":"K Shaffer","year":"2020","unstructured":"Shaffer K, Cakmakoglu C, Schwarz GS, ElSherif A, Al-Hilli Z, Djohan R et al (2020) Lymphedema prevention surgery: improved operating efficiency over time. Ann Surg Oncol 27(12):4695\u20134701","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"6758_CR21","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.jamcollsurg.2007.12.022","volume":"206","author":"C Boneti","year":"2008","unstructured":"Boneti C, Korourian S, Bland K, Cox K, Adkins LL, Henry-Tillman RS et al (2008) Axillary reverse mapping: mapping and preserving arm lymphatics may be important in preventing lymphedema during sentinel lymph node biopsy. J Am Coll Surg 206(5):1038\u201342 (discussion 1042-4)","journal-title":"J Am Coll Surg"},{"issue":"9","key":"6758_CR22","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1245\/s10434-008-0030-z","volume":"15","author":"C Nos","year":"2008","unstructured":"Nos C, Kaufmann G, Clough KB, Collignon MA, Zerbib E, Cusumano P et al (2008) Combined axillary reverse mapping (ARM) technique for breast cancer patients requiring axillary dissection. Ann Surg Oncol 15(9):2550\u20132555","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"6758_CR23","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1245\/s10434-007-9412-x","volume":"14","author":"M Thompson","year":"2007","unstructured":"Thompson M, Korourian S, Henry-Tillman R, Adkins L, Mumford S, Westbrook KC et al (2007) Axillary reverse mapping (ARM): a new concept to identify and enhance lymphatic preservation. Ann Surg Oncol 14(6):1890\u20131895","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"6758_CR24","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.ijrobp.2014.02.013","volume":"89","author":"A McBride","year":"2014","unstructured":"McBride A, Allen P, Woodward W, Kim M, Kuerer HM, Drinka EK et al (2014) Locoregional recurrence risk for patients with T1,2 breast cancer with 1\u20133 positive lymph nodes treated with mastectomy and systemic treatment. Int J Radiat Oncol*Biol*Phys 89(2):392\u20138","journal-title":"Int J Radiat Oncol*Biol*Phys"},{"key":"6758_CR25","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.critrevonc.2018.06.013","volume":"129","author":"CA Castaneda","year":"2018","unstructured":"Castaneda CA, Rebaza P, Castillo M, Gomez HL, de La Cruz M, Calderon G et al (2018) Critical review of axillary recurrence in early breast cancer. Crit Rev Oncol Hematol 129:146\u2013152","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"6758_CR26","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s10434-004-1166-0","volume":"12","author":"ML Smidt","year":"2005","unstructured":"Smidt ML, Janssen CMM, Kuster DM, Bruggink EDM, Strobbe LJA (2005) Axillary recurrence after a negative sentinel node biopsy for breast cancer: incidence and clinical significance. Ann Surg Oncol 12(1):29\u201333","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"6758_CR27","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/j.ejso.2008.01.034","volume":"34","author":"IMC van der Ploeg","year":"2008","unstructured":"van der Ploeg IMC, Nieweg OE, van Rijk MC, Vald\u00e9s Olmos RA, Kroon BBR (2008) Axillary recurrence after a tumour-negative sentinel node biopsy in breast cancer patients: a systematic review and meta-analysis of the literature. Eur J Surg Oncol 34(12):1277\u20131284","journal-title":"Eur J Surg Oncol"},{"key":"6758_CR28","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ejca.2016.01.019","volume":"58","author":"G Houvenaeghel","year":"2016","unstructured":"Houvenaeghel G, Classe JM, Garbay JR, Giard S, Cohen M, Faure C et al (2016) Survival impact and predictive factors of axillary recurrence after sentinel biopsy. Eur J Cancer 58:73\u201382","journal-title":"Eur J Cancer"},{"issue":"1","key":"6758_CR29","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s12957-016-0988-0","volume":"14","author":"P Wangchinda","year":"2016","unstructured":"Wangchinda P, Ithimakin S (2016) Factors that predict recurrence later than 5 years after initial treatment in operable breast cancer. World J Surg Oncol 14(1):223","journal-title":"World J Surg Oncol"},{"issue":"19","key":"6758_CR30","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1056\/NEJMoa1701830","volume":"377","author":"H Pan","year":"2017","unstructured":"Pan H, Gray R, Braybrooke J, Davies C, Taylor C, McGale P et al (2017) 20-Year risks of breast-cancer recurrence after stopping endocrine therapy at 5 years. NEJM 377(19):1836\u20131846","journal-title":"NEJM"},{"issue":"9","key":"6758_CR31","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1200\/JCO.2015.62.3504","volume":"34","author":"M Colleoni","year":"2016","unstructured":"Colleoni M, Sun Z, Price KN, Karlsson P, Forbes JF, Th\u00fcrlimann B et al (2016) Annual hazard rates of recurrence for breast cancer during 24 years of follow-up: results from the international breast cancer study group trials I to V. J Clin Oncol 34(9):927\u2013935","journal-title":"J Clin Oncol"},{"issue":"5","key":"6758_CR32","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1038\/bjc.2014.5","volume":"110","author":"E Colzani","year":"2014","unstructured":"Colzani E, Johansson AL, Liljegren A, Foukakis T, Clements M, Adolfsson J et al (2014) Time-dependent risk of developing distant metastasis in breast cancer patients according to treatment, age and tumour characteristics. Br J Cancer 110(5):1378\u201384","journal-title":"Br J Cancer"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-022-06758-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-022-06758-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-022-06758-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T21:59:42Z","timestamp":1701208782000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-022-06758-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,14]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["6758"],"URL":"https:\/\/doi.org\/10.1007\/s10549-022-06758-2","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,14]]},"assertion":[{"value":"21 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Author Stephanie Valente, DO is a speaker\/consultant\/advisory board member for Impedimed, Pacira, AxoGen, Merit. The remaining authors have no conflicts of interest. The corresponding author has signed the disclosure form and attached it with the manuscript stating there is no conflict of interest. Separate conflict of interest forms from remaining authors can be uploaded if needed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study received IRB approval.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}